Comparison

Loureirin B European Partner

Item no. TMO-T3876-50mg
Manufacturer TargetMol
CASRN 119425-90-0
Amount 50 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 99.91%
Citations Yin S, et al. Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cells. Cell Biosci. 2014 Dec 12;4:78.
Smiles COc1cc(OC)c(CCC(=O)c2ccc(O)cc2)c(OC)c1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 119425-90-0,ERK,JNK,PAI-1,Potassium Channel
Shipping Condition Cool pack
Available
Manufacturer - Targets
ERK|||PAI-1|||Potassium Channel|||JNK
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
316.35
Description
Loureirin B can downregulate the expression of fibrosis-related molecules by regulating MMPs and TIMPs levels, inhibit scar fibroblast proliferation and suppress TGF-β1-induced fibrosis, during which TGF-β1/Smad2/3 pathway is likely involved.
Pathways
MAPK|||Membrane transporter/Ion channel|||Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close